Sponsor: Dualitybio, Inc.
Sponsor Study ID: DB-1311-201
Study Title: A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors
CTO #: 104200
NCT Number:
Phase: II
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Cervix Uteri; Lip, Oral Cavity and Pharynx; Liver; Lung
Study Objectives: To determine the RP2D of DB-1311 in combination with BNT327 by assessing the safety and tolerability in targeted participant populations. To determine the RP2D of DB-1311 in combination with DB-1305 by assessing the safety and tolerability in targeted participant populations.